Aspirin and Vascepa are two different medications that are commonly used to treat different conditions. Aspirin is a nonsteroidal anti-inflammatory drug (NSAID) that is used to reduce pain, inflammation, and fever. Vascepa is a prescription medication that is used to reduce the risk of cardiovascular events in certain adult patient groups.
According to Drugs.com, there are no known interactions between aspirin and Vascepa. However, it is always important to consult with a healthcare provider before taking any new medications, including aspirin and Vascepa, as there may be individual factors that could increase the risk of adverse effects.
Aspirin has been associated with a number of potential risks and side effects, including gastrointestinal bleeding, ulcers, and kidney damage. The FDA warns that aspirin should not be used in certain populations, such as children and teenagers who have or are recovering from chickenpox or flu-like symptoms, due to the risk of Reye's syndrome. Additionally, individuals who have a history of bleeding disorders or stomach ulcers should use aspirin with caution.
Vascepa has also been associated with potential risks and side effects, including an increased risk of bleeding, especially in individuals who take anticoagulants or have a history of bleeding disorders. The FDA notes that Vascepa should not be used in individuals with a known hypersensitivity to the medication or its components.
In summary, while there are no known interactions between aspirin and Vascepa, both medications have potential risks and side effects that should be considered before use. It is important to consult with a healthcare provider before taking any new medications to determine if they are appropriate and safe for individual use.
Sources:
[1] https://www.drugpatentwatch.com/p/tradename/ASPIRIN
[2] https://www.fda.gov/news-events/press-announcements/fda-approves-use-drug-reduce-risk-cardiovascular-events-certain-adult-patient-groups
[3] https://www.drugs.com/drug-interactions/aspirin-with-vascepa-243-0-3407-15790.html